These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 215966)

  • 1. [Analysis of 30 hepatocellular carcinoma cases detected during the observation period for chronic hepatitis or liver cirrhosis (author's transl)].
    Imaeda T; Senda K; Kato T; Asada S; Suzuki M; Ishigaki T; Yamawaki Y; Doi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Nov; 38(11):1073-94. PubMed ID: 215966
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
    Tsukuma H; Hiyama T; Tanaka S; Nakao M; Yabuuchi T; Kitamura T; Nakanishi K; Fujimoto I; Inoue A; Yamazaki H
    N Engl J Med; 1993 Jun; 328(25):1797-801. PubMed ID: 7684822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiological factors of hepatocellular carcinoma in Abidjan (Ivory Coast) (author's transl)].
    Le Bras M; Ticolat R; Clerc M; Loubière R; Beda B; Bertrand E
    Gastroenterol Clin Biol; 1978; 2(8-9):679-88. PubMed ID: 213339
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Collazos J
    N Engl J Med; 1993 Dec; 329(25):1896-7; author reply 1897-8. PubMed ID: 7504208
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective study on the evaluation of diagnostic procedure for hepatoma in patients with cirrhosis of the liver.
    Kawata H; Shimizu Y; Kojima G; Taniguchi T; Nishiyama S
    Acta Hepatogastroenterol (Stuttg); 1974 Apr; 21(2):106-19. PubMed ID: 4375388
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
    Okuda K; Kotoda K; Obata H; Hayashi N; Hisamitsu T
    Gastroenterology; 1975 Jul; 69(1):226-34. PubMed ID: 50251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?
    Röckelein G; Hecken-Emmel M
    Hepatogastroenterology; 1988 Aug; 35(4):151-7. PubMed ID: 2846418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between hepatocellular carcinoma-developing and non-carcinoma-developing patients with cirrhosis over a long follow-up period.
    Kobayashi K; Unoura M; Tanaka N; Hattori N
    Hepatogastroenterology; 1990 Oct; 37(5):445-8. PubMed ID: 2174821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up studies on hepatoma developing from liver cirrhosis].
    Sakai T; Kishikawa Y
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1637-44. PubMed ID: 1723090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatocellular cancer (clinical and etiological aspects)].
    Mukhin AS; Eremeeva EP
    Ter Arkh; 1983; 55(2):62-6. PubMed ID: 6302934
    [No Abstract]   [Full Text] [Related]  

  • 15. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract]   [Full Text] [Related]  

  • 16. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation.
    Kita Y; Klintmalm G; Kobayashi S; Yanaga K
    Dig Dis Sci; 2007 Dec; 52(12):3392-3. PubMed ID: 17404871
    [No Abstract]   [Full Text] [Related]  

  • 17. [Follow-up study of chronic hepatitis and liver cirrhosis complicated with liver neoplasm].
    Kobayashi K; Unoura M
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1028-31. PubMed ID: 1700045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatocellular carcinogenesis in type B liver cirrhosis].
    Ikeda K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):667-72. PubMed ID: 12442465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.